I'm LongbridgeAI, I can summarize articles.Guggenheim maintained their Buy rating on Northrop Grumman's stock with a price target of $640.00.
The price target implies an upside of 19.9% from the Oct 20 close of $534.
Key takeaways from the analyst note
Strong Revenue Growth and Backlog: Northrop Grumman's management has provided optimistic guidance for 2027, anticipating a revenue growth of 5-7%, which is an acceleration compared to 2026. Additionally, the company has a record backlog of $109.6 billion, ensuring substantial sales visibility and mitigating funding uncertainties.
Robust Funding and Program Support: The company's core programs are fully funded within the FY27 budget, with strong bipartisan support in Congress. This solid funding environment, combined with the potential for additional supplemental funding, positions Northrop Grumman favorably for sustained operational performance and growth.
Explore more price target data and ratings for Northrop Grumman on the .
